Molecules is a privately-held company focused on the development of small
molecule compounds that act by unlocking protein-protein interfaces that have
been intractable targets for orally bioavailable drugs. Utilizing its unique
approach, DiCE Molecules can amplify the strongest potential drug candidates and, by
combining massive diversity with amplification and selection, substantially
increase the probability of success.